Skip to main content

The Caisse de depot et placement du Quebec (CDP) building is seen in Montreal, in this file photo

CHRISTINNE MUSCHI/REUTERS

Canadian pension fund giant Caisse de dépôt et placement du Québec and the Bronfman family's private equity firm Claridge Inc. are partnering in a new real estate development effort in the Montreal region.

Caisse property subsidiary Ivanhoé Cambridge and Claridge said Wednesday they're setting up a business alliance with the goal of investing together with private property developers in mid-sized real estate projects in and around Quebec's biggest city.

The partners are aiming to invest about $100-million and will target residential, mixed-used, light industry or low-density office building projects. The partners said a typical investment will range between $5-million and $15-million per project and that Wayne Heuff of Claridge will manage the partnership.

Story continues below advertisement

The capital deployment comes as Ivanhoé pushes ahead with a much larger $1-billion plan to redevelop Montreal's downtown core – an effort that includes a $140-million renovation of the city's Fairmont Queen Elizabeth Hotel and the construction of a new 27-storey tower to house Manulife Financial Corp.'s Quebec employees.

Claridge and Ivanhoé are also partners on a separate project to revamp the top four floors of the Place Ville Marie office tower to use as an observatory and entertainment area. The 47-storey tower, designed by architect I.M. Pei, is one of the city's most distinctive buildings.

Representing the interests of the Stephen Bronfman family, Claridge is invested in a number of businesses including Cirque du Soleil and villa rental company Luxury Retreats. Ivanhoé had assets worth a stated $55-billion at the end of 2015, including stakes in some of the world's premier properties.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies